• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

铂基配合物在肺癌治疗中的研究进展：作用机制、应用及挑战

Research Progress of Platinum-Based Complexes in Lung Cancer Treatment: Mechanisms, Applications, and Challenges.

作者信息

Liang Wanqi, Huang Yufeng, Wang Yi, Lu Desheng, Sun Qi

机构信息

Department of Pharmacology, International Cancer Center, Shenzhen University Medical School, Shenzhen 518060, China.

Shenzhen Key Lab of Functional Polymer, College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen 518060, China.

出版信息

Int J Mol Sci. 2025 Aug 18;26(16):7958. doi: 10.3390/ijms26167958.

DOI:10.3390/ijms26167958
PMID:40869279
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12386309/
Abstract

Platinum-based complexes, as one of the mainstay chemotherapeutic agents in oncology, have evolved from first-generation Cisplatin to third-generation Oxaliplatin, with numerous platinum complexes currently under clinical investigation. This review systematically evaluates all existing platinum complexes for lung cancer treatment, including three generations of approved agents and investigational candidates, with comprehensive analysis of therapeutic efficacy and toxicity profiles. Our assessment aims to provide novel insights for developing next-generation platinum complexes with optimal therapeutic potential.

摘要

铂类配合物作为肿瘤学领域的主要化疗药物之一，已从第一代顺铂发展到第三代奥沙利铂，目前有众多铂类配合物正处于临床研究阶段。本综述系统评估了所有现有的用于肺癌治疗的铂类配合物，包括三代已获批药物和处于研究阶段的候选药物，并对其治疗效果和毒性特征进行了全面分析。我们的评估旨在为开发具有最佳治疗潜力的下一代铂类配合物提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/44a8479585f8/ijms-26-07958-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/3e0fd11b5c22/ijms-26-07958-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/9e235f650da8/ijms-26-07958-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/be11a36124ec/ijms-26-07958-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/8a4959e9acfc/ijms-26-07958-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/ab4cd25a0083/ijms-26-07958-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/4f95f89ffaaa/ijms-26-07958-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/a5b274f05c3a/ijms-26-07958-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/c2d3b42a7699/ijms-26-07958-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/a41a6f3c58c8/ijms-26-07958-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/a8dfff89a435/ijms-26-07958-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/c585c1ba3493/ijms-26-07958-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/87bdb8bc2975/ijms-26-07958-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/0cb1d300b733/ijms-26-07958-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/82cb25746c00/ijms-26-07958-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/24135e348662/ijms-26-07958-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/7c474f9d4cab/ijms-26-07958-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/0291f1f43852/ijms-26-07958-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/1659f49494d5/ijms-26-07958-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/c80f1eafe36c/ijms-26-07958-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/5eddb8bb84df/ijms-26-07958-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/d6ce5d6ee939/ijms-26-07958-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/44a8479585f8/ijms-26-07958-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/3e0fd11b5c22/ijms-26-07958-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/9e235f650da8/ijms-26-07958-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/be11a36124ec/ijms-26-07958-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/8a4959e9acfc/ijms-26-07958-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/ab4cd25a0083/ijms-26-07958-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/4f95f89ffaaa/ijms-26-07958-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/a5b274f05c3a/ijms-26-07958-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/c2d3b42a7699/ijms-26-07958-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/a41a6f3c58c8/ijms-26-07958-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/a8dfff89a435/ijms-26-07958-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/c585c1ba3493/ijms-26-07958-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/87bdb8bc2975/ijms-26-07958-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/0cb1d300b733/ijms-26-07958-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/82cb25746c00/ijms-26-07958-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/24135e348662/ijms-26-07958-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/7c474f9d4cab/ijms-26-07958-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/0291f1f43852/ijms-26-07958-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/1659f49494d5/ijms-26-07958-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/c80f1eafe36c/ijms-26-07958-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/5eddb8bb84df/ijms-26-07958-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/d6ce5d6ee939/ijms-26-07958-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc39/12386309/44a8479585f8/ijms-26-07958-g022.jpg

相似文献

1
Research Progress of Platinum-Based Complexes in Lung Cancer Treatment: Mechanisms, Applications, and Challenges.铂基配合物在肺癌治疗中的研究进展：作用机制、应用及挑战
Int J Mol Sci. 2025 Aug 18;26(16):7958. doi: 10.3390/ijms26167958.
2
Chemotherapy for advanced non-small cell lung cancer in the elderly population.老年晚期非小细胞肺癌的化疗
Cochrane Database Syst Rev. 2015 Oct 20;2015(10):CD010463. doi: 10.1002/14651858.CD010463.pub2.
3
"Non-Classical" Platinum Complexes: A Concise Review.“非经典”铂配合物：简要综述
Int J Mol Sci. 2025 Jun 28;26(13):6270. doi: 10.3390/ijms26136270.
4
Copper oxide nanoparticles as delivery vehicles for different Pt(II)-drugs: experimental and theoretical evaluation.氧化铜纳米颗粒作为不同Pt(II)药物的递送载体：实验与理论评估
J Mater Chem B. 2025 Aug 13;13(32):10027-10042. doi: 10.1039/d4tb02636e.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Comparative Antitumor Efficacy and Toxicity Profile of SCC5, An Ag(I) -Heterocyclic Carbene Complex, Relative to Platinum-based Chemotherapeutics.SCC5（一种银（I）-杂环卡宾配合物）相对于铂类化疗药物的比较抗肿瘤疗效和毒性特征
Anticancer Res. 2025 Sep;45(9):3629-3637. doi: 10.21873/anticanres.17727.
7
Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review.奥沙利铂用于治疗顺铂耐药性癌症：一项系统评价
Cancer Treat Rev. 2007 Jun;33(4):347-57. doi: 10.1016/j.ctrv.2007.01.009. Epub 2007 Mar 23.
8
Chemotherapy for advanced non-small cell lung cancer in the elderly population.老年晚期非小细胞肺癌的化疗
Sao Paulo Med J. 2016 Sep-Oct;134(5):465-466. doi: 10.1590/1516-3180.20161345T1.
9
Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review.厄洛替尼或吉非替尼治疗铂类预处理复发的非小细胞肺癌和卵巢癌：系统评价。
Drug Resist Updat. 2011 Jun;14(3):177-90. doi: 10.1016/j.drup.2011.02.004. Epub 2011 Mar 24.
10
Different infusion durations for preventing platinum-induced hearing loss in children with cancer.预防癌症患儿铂类药物所致听力损失的不同输注持续时间
Cochrane Database Syst Rev. 2016 Aug 8(8):CD010885. doi: 10.1002/14651858.CD010885.pub3.

本文引用的文献

1
Platinum nanoparticles in cancer therapy: chemotherapeutic enhancement and ROS generation.铂纳米颗粒在癌症治疗中的应用：化疗增强作用与活性氧生成
Med Oncol. 2025 Jan 9;42(2):42. doi: 10.1007/s12032-024-02598-w.
2
Preliminary results of randomized phase II study of etoposide plus lobaplatin or etoposide plus cisplatin with concurrent thoracic radiotherapy in the treatment of limited-stage small cell lung cancer.依托泊苷联合洛铂或依托泊苷联合顺铂同步胸部放疗治疗局限期小细胞肺癌的随机II期研究初步结果
Anticancer Drugs. 2023 Nov 1;34(10):1183-1189. doi: 10.1097/CAD.0000000000001501. Epub 2023 Jan 24.
3
A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance.
一种克服基于谷胱甘肽的奥沙利铂耐药性的铂（IV）前药策略。
Commun Chem. 2022 Apr 6;5(1):46. doi: 10.1038/s42004-022-00661-z.
4
Lung-specific exosomes for co-delivery of CD47 blockade and cisplatin for the treatment of non-small cell lung cancer.用于共递送 CD47 阻断和顺铂的肺特异性细胞外囊泡治疗非小细胞肺癌。
Thorac Cancer. 2022 Oct;13(19):2723-2731. doi: 10.1111/1759-7714.14606. Epub 2022 Aug 27.
5
MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin.MicroRNAs 作为预测肺癌对顺铂耐药和敏感的标志物。
Int J Mol Sci. 2022 Jul 8;23(14):7594. doi: 10.3390/ijms23147594.
6
In vitro and in vivo antitumor studies of potential anticancer agents of platinum(II) complexes of dicyclopentadiene and dithiocarbamates§.二环戊二烯与二硫代氨基甲酸盐的铂（II）配合物潜在抗癌剂的体外和体内抗肿瘤研究§
Metallomics. 2022 Aug 9;14(8). doi: 10.1093/mtomcs/mfac054.
7
A chemical perspective on the clinical use of platinum-based anticancer drugs.从化学角度看临床应用的铂类抗癌药物。
Dalton Trans. 2022 Jul 26;51(29):10835-10846. doi: 10.1039/d2dt01875f.
8
Platinum(IV) Prodrugs with Cancer Stem Cell Inhibitory Effects on Lung Cancer for Overcoming Drug Resistance.具有癌症干细胞抑制作用的铂（IV）前药可克服肺癌的耐药性。
J Med Chem. 2022 Jun 9;65(11):7933-7945. doi: 10.1021/acs.jmedchem.2c00472. Epub 2022 May 30.
9
Platinum Nanoparticles: The Potential Antioxidant in the Human Lung Cancer Cells.铂纳米颗粒：人类肺癌细胞中的潜在抗氧化剂。
Antioxidants (Basel). 2022 May 18;11(5):986. doi: 10.3390/antiox11050986.
10
Antiproliferative activity and DNA binding studies of cyclometalated complexes of platinum(II) containing 2-vinylpyridine.含 2-乙烯基吡啶的铂（II）环金属配合物的抗增殖活性和 DNA 结合研究。
Biometals. 2022 Jun;35(3):617-627. doi: 10.1007/s10534-022-00392-7. Epub 2022 Apr 21.